Equity ratings for STRIDES PHARMA SCI are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of June 2021 and ending today, the 30th of July 2021. Click here to learn more.
STRIDES PHARMA SCI cannot be verified against its exchange. Apparently, STRIDES PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.


Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australasia, North America, Europe, Asia, India, and internationally. Strides Pharma Science Limited was founded in 1990 and is headquartered in Bengaluru, India. STRIDES PHARMA operates under Drug Manufacturers - Specialty Generic classification in India and is traded on National Stock Exchange of India.. The public information regarding STRIDES PHARMA SCI's current market price is not available at this time.
STRIDES PHARMA SCI is not yet fully synchronised with the market data
STRIDES PHARMA SCI has some characteristics of a very speculative penny stock
STRIDES PHARMA SCI has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
ChairmanDeepak Vaidya  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of STRIDES PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
STRIDES PHARMA SCI (STAR) is traded on National Stock Exchange of India in India and employs 5,800 people. The company currently falls under 'Large-Cap' category with current market capitalization of 34.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate STRIDES PHARMA's market, we take the total number of its shares issued and multiply it by STRIDES PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. STRIDES PHARMA SCI operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 89.55 M outstanding shares. STRIDES PHARMA SCI has accumulated about 7.92 B in cash with 834 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 88.43.
Check STRIDES PHARMA Probability Of Bankruptcy

STRIDES Stock Against Markets

Picking the right benchmark for STRIDES PHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in STRIDES PHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for STRIDES PHARMA is critical whether you are bullish or bearish towards STRIDES PHARMA SCI at a given time.
STRIDES PHARMA SCI cannot be verified against its exchange. Apparently, STRIDES PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with STRIDES PHARMA stock to make a market-neutral strategy. Peer analysis of STRIDES PHARMA could also be used in its relative valuation, which is a method of valuing STRIDES PHARMA by comparing valuation metrics with similar companies.

STRIDES PHARMA Corporate Directors

STRIDES PHARMA corporate directors refer to members of a STRIDES PHARMA board of directors. The board of directors generally takes responsibility for the STRIDES PHARMA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of STRIDES PHARMA's board members must vote for the resolution. The STRIDES PHARMA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
M Umarji - Independent Non-Executive DirectorProfile
Srinivasan Sridhar - Non-Executive Independent DirectorProfile
Sangita Reddy - Independent DirectorProfile
A Nair - Independent Non-Executive DirectorProfile
Check out World Market Map. Note that the STRIDES PHARMA SCI information on this page should be used as a complementary analysis to other STRIDES PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Tools for STRIDES Stock

When running STRIDES PHARMA SCI price analysis, check to measure STRIDES PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STRIDES PHARMA is operating at the current time. Most of STRIDES PHARMA's value examination focuses on studying past and present price action to predict the probability of STRIDES PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move STRIDES PHARMA's price. Additionally, you may evaluate how the addition of STRIDES PHARMA to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity